Bayer 17096, A Phase II Randomized, Double-blind, Placebo-controlled Trial of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus When Administered to Metastatic Her2 Negative Hormone Receptor Positive Breast Cancer Subjects With Bone Metastases

9315-CTO
Cancer - Breast
Open